Last reviewed · How we verify
Octenidine Dihydrocloride in aqueous solution
Octenidine Dihydrocloride in aqueous solution is a Small molecule drug developed by Becton, Dickinson and Company. It is currently in Phase 2 development.
At a glance
| Generic name | Octenidine Dihydrocloride in aqueous solution |
|---|---|
| Sponsor | Becton, Dickinson and Company |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Octenidine Dihydrocloride in aqueous solution CI brief — competitive landscape report
- Octenidine Dihydrocloride in aqueous solution updates RSS · CI watch RSS
- Becton, Dickinson and Company portfolio CI
Frequently asked questions about Octenidine Dihydrocloride in aqueous solution
What is Octenidine Dihydrocloride in aqueous solution?
Octenidine Dihydrocloride in aqueous solution is a Small molecule drug developed by Becton, Dickinson and Company.
Who makes Octenidine Dihydrocloride in aqueous solution?
Octenidine Dihydrocloride in aqueous solution is developed by Becton, Dickinson and Company (see full Becton, Dickinson and Company pipeline at /company/becton-dickinson-and-company).
What development phase is Octenidine Dihydrocloride in aqueous solution in?
Octenidine Dihydrocloride in aqueous solution is in Phase 2.
Related
- Manufacturer: Becton, Dickinson and Company — full pipeline